zoom_in
Click to enlarge
description AbbVie (ABBV) Overview
AbbVie is a research-based biopharmaceutical company with a strong portfolio of drugs, including Humira. While facing patent expirations for some key products, AbbVie is actively investing in research and development to create new innovative therapies. The company offers a high dividend yield, currently around 4.0%, and has a history of dividend increases. Its suitable for investors seeking a high dividend yield and exposure to the pharmaceutical sector, but should be considered with an understanding of the companys patent landscape.
help AbbVie (ABBV) FAQ
What is AbbVie (ABBV)?
AbbVie is a research-based biopharmaceutical company with a strong portfolio of drugs, including Humira. While facing patent expirations for some key products, AbbVie is actively investing in research and development to create new innovative therapies. The company offers a high dividend yield, currently around 4.0%, and has a history of dividend increases. Its suitable for investors seeking a high dividend yield and exposure to the pharmaceutical sector, but should be considered with an understanding of the companys patent landscape.
How good is AbbVie (ABBV)?
AbbVie (ABBV) scores 8.3/10 (Very Good) on Lunoo, making it a well-rated option in the Dividend Stocks category.
What are the best alternatives to AbbVie (ABBV)?
See our alternatives page for AbbVie (ABBV) for a ranked list with scores. Top alternatives include: Johnson & Johnson (JNJ), Amgen (AMGN), Coca-Cola (KO).
How does AbbVie (ABBV) compare to Johnson & Johnson (JNJ)?
See our detailed comparison of AbbVie (ABBV) vs Johnson & Johnson (JNJ) with scores, features, and an AI-powered verdict.
Is AbbVie (ABBV) worth it in 2026?
With a score of 8.3/10, AbbVie (ABBV) is highly rated in Dividend Stocks. See all Dividend Stocks ranked.
explore Explore More
Similar to AbbVie (ABBV)
See all arrow_forward
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
